It has been shown that ERK phosphorylation catalyzed by activated MAPK/ERK kinases (MEK) downstream of the Ras proto-oncogene transduces the activation of the MAPK/ERK pathway, playing a critical role in controlling cell proliferation, apoptosis, cell cycle, and drug resistance in MM. The gene discussed is MAP2K7; the disease is Miyoshi myopathy.